Smoking boosts clopidogrel effect in people with diabetes and CAD

04/9/2012 | Medscape (free registration)

Data on 134 patients with type 2 diabetes and coronary artery disease who were on maintenance clopidogrel therapy showed that those who smoked were less likely to suffer from high on-treatment platelet reactivity than nonsmokers. However, researchers warned that cardiovascular events, including mortality, remained higher for smokers. The results were published in JACC: Cardiovascular Interventions.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY